Ticker Details
Rapport Therapeutics, Inc. Common Stock
IPO Date:	June 7, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.31B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.99 | 4.73%
Avg Daily Range (30 D):	$1.37 | 3.19%
Avg Daily Range (90 D):	$1.17 | 2.97%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	.23M
Avg Daily Volume (90 D):	.27M

Trade Size
Avg Trade Size (Sh.):	54
Avg Trade Size (Sh.) (30 D):	43
Avg Trade Size (Sh.) (90 D):	46

Institutional Trades
Total Institutional Trades:	463
Avg Institutional Trade:	$1.66M
Avg Institutional Trade (30 D):	$1.67M
Avg Institutional Trade (90 D):	$1.89M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.06M
Avg Closing Trade (30 D):	$1.92M
Avg Closing Trade (90 D):	$2.24M
Avg Closing Volume:	72.21K

News

Apr 1, 2026 @ 11:00 AM Rapport Therapeutics to Present New Phase 2 Treatm... Source: Na

Sep 10, 2025 @ 1:17 AM Rapport Announces Pricing of Public Offering of Co... Source: Globe Newswire

Jun 12, 2025 @ 8:22 PM Analysts Can't Get Enough of These Little-Known Bi... Source: Marketbeat.Com

Jun 2, 2025 @ 6:45 PM Rapport Therapeutics Hosts Investor and Analyst Da... Source: Rapport Therapeutics, Inc.

Mar 21, 2025 @ 11:00 AM Rapport Therapeutics to Present Data at the 2025 A... Source: N/A

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-3.03	$-1.19	$-.42
Diluted EPS	$-3.03	$-1.19	$-.42
Revenue	$20M	$M	$20M
Gross Profit
Net Income / Loss	$-137.16M	$-56.62M	$-19.86M
Operating Income / Loss	$-153.52M	$-60.81M	$-24.22M
Cost of Revenue
Net Cash Flow	$8.55M	$-14.44M	$25.41M
PE Ratio